TFR2 and myeloid sarcoma: On the other hand, at least one C allele in the single-nucleotide polymorphism (SNP) rs7385804 TFR2 range may be associated with de novo diagnosis of the disease, because patients with AC and CC genotypes are significantly less likely to develop MS in straight line relatives.